Alvotech is trading at ISK 716.00, down 4.02% on October 8, 2026, with no clear company-specific explanation identified.
- No company-specific announcement dated October 8 clearly explains the decline.
- The latest updates were an October 6 manufacturing agreement with LOTTE Biologics and October 5 FDA news; neither establishes a cause.
- Rising yields and oil prices weighed on markets on October 7, but available evidence does not directly link that backdrop to Alvotechβs decline.